Theriva Biologics, Inc. (TOVX) News
Follow Theriva Biologics, Inc. (TOVX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Theriva Biologics, Inc. (TOVX) VIRAGE Phase 2b Results Published; VIRAGE2 Underway
Theriva Biologics said VIRAGE Phase 2b data for VCN-01 in metastatic pancreatic cancer were published in Nature Medicine, showing improved OS, PFS and DoR vs SoC. The company has initiated VIRAGE2 to assess more frequent
NEWS | Sep 30, 2026, 12:09 PM UTC
L
Theriva™ Biologics Announces Publication of the Results from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer Published in Nature Medicine
Publication in this premier journal after rigorous peer review validates the VIRAGE study and supports the continued evaluation of VCN-01 in the treatment of metastatic pancreatic cancer -- Data are consistent with an im
NEWS | Sep 30, 2026, 12:08 PM UTC
M
TOVX Starts VIRAGE2 Trial For Metastatic Pancreatic Cancer
TOVX begins clinical trial for pancreatic cancer treatment
EQUITY | Aug 06, 2026, 12:00 PM UTC